Evidence map›Paper›PMID 32392461›Full record

ArticleEuropean journal of rheumatology2020

The emerging role of lung ultrasound in COVID-19 pneumonia.

Gemma Lepri, Martina Orlandi, Chiara Lazzeri, Cosimo Bruni, Michael Hughes, Manuela Bonizzoli, Yukai Wang, Adriano Peris, Marco Matucci-Cerinic

Open access · diamondAbstract read
In one paragraph

Article in European journal of rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Gemma LepriDivision of Rheumatology, Department of Experimental and Clinical Medicine, Università degli Studi di Firenze, Firenze, Toscana, Italy.ORCID https://orcid.org/0000-0003-4141-6937
Martina OrlandiDivision of Rheumatology, Department of Experimental and Clinical Medicine, Università degli Studi di Firenze, Firenze, Toscana, Italy.ORCID https://orcid.org/0000-0001-6784-2235
Chiara LazzeriDepartment of Emergency, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.ORCID https://orcid.org/0000-0003-0131-4450
Cosimo BruniDivision of Rheumatology, Department of Experimental and Clinical Medicine, Università degli Studi di Firenze, Firenze, Toscana, Italy.ORCID https://orcid.org/0000-0003-2813-2083
Michael HughesDepartment of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.ORCID https://orcid.org/0000-0003-3361-4909
Manuela BonizzoliDepartment of Emergency, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.ORCID https://orcid.org/0000-0002-6435-5754
Yukai WangDepartment of Rheumatology and Immunology, Shantou Central Hospital, Shantou, China.ORCID https://orcid.org/0000-0003-2468-3208
Adriano PerisDepartment of Emergency, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.ORCID https://orcid.org/0000-0003-0724-4422
Marco Matucci-CerinicDivision of Rheumatology, Department of Experimental and Clinical Medicine, Università degli Studi di Firenze, Firenze, Toscana, Italy.ORCID https://orcid.org/0000-0002-9324-3161
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · ITShantou Central Hospital · CNSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decades lung ultrasound (LUS) has become of crucial importance in the evaluation and monitoring of a widely range of pulmonary diseases. One of the major benefits which favours this examination, is that this is a non-invasive, low-cost and radiation-free imaging modality which allows repeated imaging. LUS plays an important role in a wide range of pathologies, including cardiogenic oedema, acute respiratory distress syndrome and fibrosis. Specific LUS findings have proved useful and predictive of acute respiratory distress syndrome which is of particular relevance in the suspicion and monitoring of patients with lung disease. Furthermore, several studies have confirmed the role of LUS in the screening of interstitial lung diseases in connective tissue diseases. Given these data, LUS will likely play an important role in the management of COVID-19 patients from identification of specific abnormalities corresponding to definite pneumonia phases and CT scans findings. In addition, LUS could allow reduction in the exposure of health-care workers to potential infection. Herein, we provide a summary on emerging role of lung ultrasound in COVID-19 pneumonia.

Identifiers

PMID32392461
PMCPMC7431334
OpenAlexW3021070065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.